As of 3:59pm ET
| -0.45 / -3.57%|
The 6 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 17.50, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a +44.03% increase from the last price of 12.15.
The current consensus among 6 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.